 |
 |
|
|
MANAGEMENT Michael J. Magliochetti, Ph.D. – President and CEO , was previously an Entrepreneur-in-Residence at Oxford Bioscience Partners. He was most recently CEO of RMH, a company focused in orthopedics, which was acquired. He was CEO of HemaMetrics, a private blood monitoring and diagnostic company. Dr. Magliochetti was CEO of UroSurge, specializing in products for the urology market of which a sale transaction was executed. He has held senior positions with the medical device company Haemonetics Corporation and the polymer products company Delta Surprenant. He currently serves on the Advisory Board for the Pediatric New Technology Initiatives Group of Boston Children’s Hospital, the non-profit Institute for Pediatric Innovation, and has served as an Adjunct Professor of Biomedical Engineering at the University of Iowa. Dr. Magliochetti holds B.S. and Ph.D. degrees in Chemical Engineering from Northeastern University and the University of Massachusetts at Amherst, respectively, and a High Technology M.B.A. from Northeastern University.
David Steinmiller – Claros Founder and Chief Operating Officer , previously served as Director of Engineering at WebOligos and Eos Biotechnology where he developed instruments for genomics research. Mr. Steinmiller created and patented a high-throughput system for synthesizing nucleic acids and transitioned the technology from concept to prototype to production device. This technology formed the core of WebOligos, which produced and marketed synthetic DNA, and which was acquired by Invitrogen. Mr. Steinmiller holds a B.S. and M.S. in Mechanical Engineering from Stanford and an MBA from the MIT Sloan School of Management.
Vincent Linder, Ph.D. – Claros Founder and CTO , co-invented the Claros technology, while being a post-doctorate fellow in George Whitesides’ laboratory at Harvard. Dr. Linder also worked as Group Leader in microfluidics at the University of Neuchatel (Switzerland), and has served as Research Scientist at CSEM (Switzerland), a leading company in micro/nanotechnology and microelectronics. He holds a M.Sc. in Chemistry and a Ph.D. in Science from the University of Neuchatel, where he performed research in the area of microfluidic technology for immunoassays with Prof. Nicolas de Rooij, one of the pioneers in the field of microfluidics.
|